Novo CEO pressed by Senate to cut prices of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the business would think about new talks with insurers in regards to the listing price ranges of Wegovy and copyright when they pledge to help keep the medicines on their formularies. https://daveshotchickennutrition49382.webbuzzfeed.com/31182057/healthcare-news-secrets